Article Information
History
- May 12, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-ND 4.0 International license.
Author Information
- Laura F. Mendez Luque1,2,
- Julio Avelar-Barragan3,
- Hellen Nguyen1,
- Jenny Nguyen1,
- Eli M. Soyfer1,
- Jiarui Liu1,
- Jane H. Chen1,
- Nitya Mehrotra1,
- Heidi E. Kosiorek4,
- Amylou Dueck4,
- Alexander Himstead1,
- Elena Heide1,
- Melinda Lem1,
- Kenza El Alaoui1,
- Eduard Mas Marin1,
- Robyn M. Scherber5,
- Ruben A. Mesa6,
- Katrine L. Whiteson3,
- Andrew Odegaard1 and
- Angela G. Fleischman1,*
- 1University of California, Irvine School of Medicine
- 2Teaching and Research Department, Institute of Public Health Services of the State of Baja California
- 3Department of Molecular Biology and Biochemistry, University of California Irvine
- 4Department of Quantitative Health Sciences, Mayo Clinic Arizona, Scottsdale, AZ
- 5Mays Cancer Center, UT Health San Antonio
- 6Atrium Health, Levine Cancer Institute, Charlotte, NC
- ↵*Corresponding Author:
Angela G. Fleischman, 839 Medical Sciences Rd, Sprague Hall 126, Irvine, CA 92617, agf{at}uci.edu, P: (949) 824-2559, F: (888) 857-1020
Posted May 12, 2023.
The NUTRIENT Trial (NUTRitional Intervention among myEloproliferative Neoplasms): Feasibility Phase
